Biotech · Private company
Spectrum Pharmaceuticals, Inc
Track this companyFree. Adds Spectrum Pharmaceuticals, Inc to your Dealase workspace and tells you when its record changes.
Clinical trials252 recruiting or active
Pipeline programs22From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline22
- CyclophosphamidePhase 3 · NeutropeniaClinicalTrials.gov · fetched Nov 12, 2026
- DocetaxelPhase 3 · NeutropeniaClinicalTrials.gov · fetched Nov 12, 2026
- DocetaxelPhase 3 · NSCLCClinicalTrials.gov · fetched Nov 12, 2026
- In-111 ZevalinPhase 3 · Diffuse Large B-cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- PegfilgrastimPhase 3 · NeutropeniaClinicalTrials.gov · fetched Nov 12, 2026
- PoziotinibPhase 3 · NSCLCClinicalTrials.gov · fetched Nov 12, 2026
- R-CVPPhase 3 · Follicular LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- RituximabPhase 3 · Diffuse Large B-cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- SPI-2012Phase 3 · NeutropeniaClinicalTrials.gov · fetched Nov 12, 2026
- Y-90-ZevalinPhase 3 · Diffuse Large B-cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- ZevalinPhase 3 · Lymphoma, Large Cell, DiffuseClinicalTrials.gov · fetched Nov 12, 2026
- ZevalinPhase 3 · Diffuse Large B-cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- Zevalin Therapeutic RegimenPhase 3 · Follicular LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- ChemotherapyPhase 2 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- EflapegrastimPhase 2 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- LoperamidePhase 2 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- ozarelixPhase 2 · Benign Prostatic Hyperplasia (BPH)ClinicalTrials.gov · fetched Nov 12, 2026
- PoziotinibPhase 2 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- Poziotinib HydrochloridePhase 2 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- EflapegrastimPhase 1 · NeutropeniaClinicalTrials.gov · fetched Nov 12, 2026
- IGN002Phase 1 · NHLClinicalTrials.gov · fetched Nov 12, 2026
- IGN002Phase 1 · Non-Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- A Study of Poziotinib in Previously Treated Participants With Locally Advanced or Metastatic NSCLC Harboring HER2 Exon 20 MutationsPHASE3 · SUSPENDED · started May 12, 2022ClinicalTrials.gov NCT05378763 · fetched Nov 12, 2026
- A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive ChemotherapyPHASE2 · RECRUITING · started May 20, 2021ClinicalTrials.gov NCT04570423 · fetched Nov 12, 2026
- A Study of IGN002 for Refractory NHLPHASE1 · WITHDRAWN · started Jan 1, 2021ClinicalTrials.gov NCT02847949 · fetched Nov 12, 2026
- Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-CancerPHASE1 · COMPLETED · started Mar 11, 2020ClinicalTrials.gov NCT04187898 · fetched Nov 12, 2026
- A Study of Poziotinib in Patients With Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Activating Mutations in Advanced MalignanciesPHASE2 · TERMINATED · started Dec 23, 2019ClinicalTrials.gov NCT04172597 · fetched Nov 12, 2026
- A Study to Allow Continued Dosing and/or Follow-up of Patients Who Have Had Previous Exposure to PoziotinibPHASE2 · TERMINATED · started Oct 11, 2018ClinicalTrials.gov NCT03744715 · fetched Nov 12, 2026
- Propylene Glycol-Free Melphalan Hydrochloride (Evomela) in AL Amyloidosis PatientsPHASE2 · TERMINATED · started Jan 8, 2018ClinicalTrials.gov NCT02994784 · fetched Nov 12, 2026
- Phase 2 Study of Poziotinib in Participants With NSCLC Having EGFR or HER2 Exon 20 Insertion MutationPHASE2 · TERMINATED · started Oct 11, 2017ClinicalTrials.gov NCT03318939 · fetched Nov 12, 2026
- Vincristine Sulfate Liposome Injection (Marqibo®), Bendamustine and Rituximab-Phase I Trial in Indolent B-cell LymphomaPHASE1 · COMPLETED · started May 10, 2017ClinicalTrials.gov NCT02257242 · fetched Nov 12, 2026
- SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and CyclophosphamidePHASE3 · COMPLETED · started May 10, 2017ClinicalTrials.gov NCT02953340 · fetched Nov 12, 2026
- Poziotinib in EGFR Exon 20 Mutant Advanced NSCLCPHASE2 · TERMINATED · started Mar 17, 2017ClinicalTrials.gov NCT03066206 · fetched Nov 12, 2026
- Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction ChemotherapyPHASE1 · COMPLETED · started Jan 31, 2017ClinicalTrials.gov NCT02879643 · fetched Nov 12, 2026
- Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant.PHASE1 · ACTIVE_NOT_RECRUITING · started Sep 1, 2016ClinicalTrials.gov NCT02909036 · fetched Nov 12, 2026
- Phase 1, Dose-Escalation Study of IGN002 in NHL SubjectsPHASE1 · TERMINATED · started May 1, 2016ClinicalTrials.gov NCT02519270 · fetched Nov 12, 2026
- Study of Poziotinib in Participants With HER2-Positive Metastatic Breast CancerPHASE2 · COMPLETED · started Feb 22, 2016ClinicalTrials.gov NCT02659514 · fetched Nov 12, 2026
- SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE)PHASE3 · COMPLETED · started Jan 19, 2016ClinicalTrials.gov NCT02643420 · fetched Nov 12, 2026
- MRSI to Predict Response to RT/TMZ ± Belinostat in GBMPHASE2 · COMPLETED · started May 7, 2014ClinicalTrials.gov NCT02137759 · fetched Nov 12, 2026
- Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast CancerPHASE2 · COMPLETED · started Mar 25, 2013ClinicalTrials.gov NCT01724866 · fetched Nov 12, 2026
- Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin LymphomaPHASE2 · UNKNOWN · started Mar 12, 2013ClinicalTrials.gov NCT01811368 · fetched Nov 12, 2026
- Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic LeukemiaPHASE2 · COMPLETED · started Mar 5, 2013ClinicalTrials.gov NCT01319981 · fetched Nov 12, 2026
- Study of Zevalin Versus Observation in Participants at Least 60 Years Old With Newly Diagnosed Diffuse Large B-cell Lymphoma in Positron Emission Tomography (PET)-Negative Complete Remission After Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) or R-CHOP-like TherapyPHASE3 · TERMINATED · started Apr 19, 2012ClinicalTrials.gov NCT01510184 · fetched Nov 12, 2026
- Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin LymphomaPHASE2 · COMPLETED · started Jul 6, 2011ClinicalTrials.gov NCT01336933 · fetched Nov 12, 2026
- Trial of the Safety and Efficacy of Ozarelix in Participants With Benign Prostatic Hyperplasia (BPH)PHASE2 · TERMINATED · started Dec 4, 2008ClinicalTrials.gov NCT00743184 · fetched Nov 12, 2026
- Phase 3 Study of Zevalin Following R-CVP in Previously Untreated Patients With Follicular Non Hodgkin's Lymphoma (NHL)PHASE3 · TERMINATED · started Oct 1, 2006ClinicalTrials.gov NCT00384111 · fetched Nov 12, 2026
- Study Comparing Zevalin Regimen With no Further Treatment in Patients With Diffuse Large B-cell Lymphoma.PHASE3 · TERMINATED · started May 1, 2006ClinicalTrials.gov NCT00322218 · fetched Nov 12, 2026